Latest Breaking News On - Effect sizes - Page 1 : vimarsana.com

Admissions policies that consider grades in context of available opportunities linked to college success

Admissions policies that consider grades in context of available opportunities linked to college success
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.

United statesBo kyung byunMichaeln bastedoYiping baiMark umbrichtEmma bauschMichael bastedoSupreme courtUniversity of north carolinaEffect sizes for high schoolYear collegeUniversity of michiganEffect sizesHigh schoolFirst year collegeNorth carolina

Axsome to Present Results of SHARP Study at Psych Congress

Axsome is set to present new data on Sunosi (solriamfetol) in patients with excessive daytime sleepiness (EDS) due to narcolepsy and OSA.

David gozalJohannes gutenbergCraig chepkeHans van dongenWashington state universityAxsome therapeutics incMedicine centerPsych congressUniversity of missouriCecilia brainCognitive functionObstructive sleep apneaWashington stateSolriamfetol improves cognitive performancePreclinical modelsSleep apnea

Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW.

New yorkUnited statesMark jacobsonDarren oplandAndrew cutlerManish jhaJohannes gutenbergRakesh jainCraig chepkeHans van dongenDavid gozalDrug administrationCorporate communicationsUniversity of missouriAffairs at axsomeUs psych congress

Axsome to Present New Sunosi Data at SLEEP 2023

Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.

United kingdomRussell rosenbergHans van dongenJohannes gutenbergDepartment of neurologyAxsome therapeutics incNeurotrials researchProfessor at washington state universityMedicine centerWashington state universityDrug administrationCognitive healthApnea participants duringRandomized placebo controlledObstructive sleep apneaExcessive daytime

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 Axsome Therapeutics, Inc. , a. | June 1, 2023

United kingdomUnited statesNew yorkDarren oplandHans van dongenJohannes gutenbergMark jacobsonRussell rosenbergResearch societyWorld trade centerDrug administrationNeurotrials researchCorporate communicationsProfessor at washington state universityUs drug enforcement agency onSk biopharmaceuticals co ltd